RESUMO
The canine corpus luteum (CL) is able to synthetise, activate and deactivate 17b-estradiol (E2) and also expresses nuclear estrogen receptors in a time-dependent manner during diestrus. Nevertheless, we are still missing a better comprehension of E2 functions in the canine CL, especially regarding the specific roles of estrogen receptor alpha (ERa) and ERb, encoded by ESR1 and 2, respectively. For that purpose, we analyzed transcriptomic data of canine non-pregnant CL collected on days 10, 20, 30, 40, 50 and 60 of diestrus and searched for differentially expressed genes (DEG) containing predicted transcription factor binding sites (TFBS) for ESR1 or ESR2. Based on biological functions of DEG presenting TFBS, expression of select transcripts and corresponding proteins was assessed. Additionally, luteal cells were collected across specific time points during diestrus and specificity of E2 responses was tested using ERa and/or ERb inhibitors. Bioinformatic analyses revealed 517 DEGs containing TFBS, from which 67 for both receptors. In general, abundance of predicted ESR1 targets was greater in the beginning, while abundance of ESR2 targets was greater in the end of diestrus. ESR1/ESR2 ratio shifted from an increasing to a decreasing pattern from day 30 to 40 post ovulation. Specific receptor inhibition suggested an ERa-mediated positive regulation of CL function at the beginning of diestrus and an ERb-mediated effect contributing to luteal regression. In conclusion, our data points toward a broad spectrum of action of E2 and its nuclear receptors, which can also act as transcription factors for other genes regulating canine CL function.
RESUMO
We hypothesized that stimulatory and superovulatory treatments, using equine chorionic gonadotropin (eCG), modulate the expression of genes related to insulin, cellular modelling and angiogenesis signaling pathways in the bovine corpus luteum (CL). Therefore, we investigated: 1-the effect of these treatments on circulating insulin and somatomedin C concentrations and on gene and protein expression of INSR, IGF1 and IGFR1, as well as other insulin signaling molecules; 2-the effects of eCG on gene and protein expression of INSR, IGF1, GLUT4 and NFKB1A in bovine luteal cells; and 3-the effect of stimulatory and superovulatory treatments on gene and protein expression of ANG, ANGPT1, NOS2, ADM, PRSS2, MMP9 and PLAU. Serum insulin did not differ among groups (P = 0.96). However, serum somatomedin C levels were higher in both stimulated and superovulated groups compared to the control (P = 0.01). In stimulated cows, lower expression of INSR mRNA and higher expression of NFKB1A mRNA and IGF1 protein were observed. In superovulated cows, lower INSR mRNA expression, but higher INSR protein expression and higher IGF1, IGFR1 and NFKB1A gene and protein expression were observed. Expression of angiogenesis and cellular modelling pathway-related factors were as follows: ANGPT1 and PLAU protein expression were higher and MMP9 gene and protein expression were lower in stimulated animals. In superovulated cows, ANGPT1 mRNA expression was higher and ANG mRNA expression was lower. PRSS2 gene and protein expression were lower in both stimulated and superovulated animals related to the control. In vitro, eCG stimulated luteal cells P4 production as well as INSR and GLUT4 protein expression. In summary, our results suggest that superovulatory treatment induced ovarian proliferative changes accompanied by increased expression of genes providing the CL more energy substrate, whereas stimulatory treatment increased lipogenic activity, angiogenesis and plasticity of the extracellular matrix (ECM).
Assuntos
Corpo Lúteo/efeitos dos fármacos , Corpo Lúteo/fisiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Gonadotropinas Equinas/farmacologia , Animais , Bovinos , Corpo Lúteo/citologia , Corpo Lúteo/metabolismo , Feminino , Insulina/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Ovulação/efeitos dos fármacos , Ovulação/genética , Progesterona/biossínteseRESUMO
This study aimed to determine in the canine corpus luteum throughout the dioestrus (1) the influence of insulin on glucose uptake; (2) the regulation of genes potentially involved; and (3) the influence of hypoxia on glucose transporter expression and steroidogenesis, after treatment with cobalt chloride (CoCl2). Glucose uptake by luteal cells increased 2.7 folds (P < 0.05) in response to insulin; a phenomenon related to increased expression of glucose transporter (GLUT) 4 and phosphorylation of protein kinase B (AKT). The gene expression of insulin receptor and SLC2A4 (codifier of GLUT4) genes after insulin stimulation increased on day 20 post ovulation (p.o.) and declined on day 40 p.o. (P < 0.05). Regarding potentially involved molecular mechanisms, the nuclear factor kappa B gene RELA was upregulated on days 30/40 p.o., when SLC2A4 mRNA was low, and the interleukin 6 (IL6) gene was upregulated in the first half of dioestrus, when SLC2A4 mRNA was high. CoCl2 in luteal cell cultures increased the hypoxia-inducible factor HIF1A/HIF1A and the SLC2A4/GLUT4 expression, and decreased progesterone (P4) production and hydroxyl-delta-5-steroid dehydrogenase 3 beta (HSD3B) mRNA expression (P < 0.05). This study shows that the canine luteal cells are responsive to insulin, which stimulates glucose uptake in AKT/GLUT4-mediated pathway; that may be related to local activity of RELA and IL6. Besides, the study reveals that luteal cells under hypoxia activate HIF1A-modulating luteal function and insulin-stimulated glucose uptake. These data indicate that insulin regulates luteal cells' glucose disposal, participating in the maintenance and functionality of the corpus luteum.
Assuntos
Corpo Lúteo/metabolismo , Cães/metabolismo , Insulina/metabolismo , Animais , Transporte Biológico Ativo/efeitos dos fármacos , Cobalto/farmacologia , Manutenção do Corpo Lúteo/genética , Manutenção do Corpo Lúteo/metabolismo , Cães/genética , Feminino , Expressão Gênica/efeitos dos fármacos , Glucose/metabolismo , Transportador de Glucose Tipo 1/genética , Transportador de Glucose Tipo 1/metabolismo , Transportador de Glucose Tipo 4/genética , Transportador de Glucose Tipo 4/metabolismo , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Insulina/fisiologia , Interleucina-6/genética , Interleucina-6/metabolismo , Células Lúteas/efeitos dos fármacos , Células Lúteas/metabolismo , Gravidez , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Fator de Transcrição RelA/genética , Fator de Transcrição RelA/metabolismoRESUMO
The canine corpus luteum (CL) functions as a source of progesterone (P4) and 17ß-oestradiol (E2); however, the transport of energy substrates to maintain its high hormonal output has not yet been characterised. This study involved the localisation and temporal distribution of the facilitative glucose transporter 1 and the quantification of the corresponding protein (GLUT1) and gene (SLC2A1) expression. Some GLUT1/SLC2A1 regulatory proteins, such as hypoxia-inducible factor 1α (HIF1A) and fibroblast growth factor 2 (FGF2); mRNAs, such as HIF1A, FGF2 and vascular endothelial growth factor A (VEGFA); and VEGFA receptors 1 and 2 (FLT1 and KDR) were also analysed from days 10 to 70 after ovulation. Additionally, plasma P4 and E2 levels were assessed via chemiluminescence. Moreover, the canine KDR sequence has been cloned, thereby enabling subsequent semi-quantitative PCR analysis. Our results demonstrate time-dependent variations in the expression profile of SLC2A1 during dioestrus, which were accompanied by highly correlated changes (0.84Assuntos
Corpo Lúteo/metabolismo
, Ciclo Estral/metabolismo
, Transportador de Glucose Tipo 1/metabolismo
, Hipóxia/metabolismo
, Animais
, Cães
, Estradiol/sangue
, Ciclo Estral/genética
, Feminino
, Fator 2 de Crescimento de Fibroblastos/genética
, Fator 2 de Crescimento de Fibroblastos/metabolismo
, Regulação da Expressão Gênica
, Transportador de Glucose Tipo 1/genética
, Hipóxia/genética
, Subunidade alfa do Fator 1 Induzível por Hipóxia/genética
, Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo
, Progesterona/sangue
, Fator A de Crescimento do Endotélio Vascular/genética
, Fator A de Crescimento do Endotélio Vascular/metabolismo
, Receptor 1 de Fatores de Crescimento do Endotélio Vascular/genética
, Receptor 1 de Fatores de Crescimento do Endotélio Vascular/metabolismo
RESUMO
Com o intuito de investigar se a hipóxia representa um dos desencadeadores da regressão luteínica em cadelas não prenhes, o presente estudo foi delineado para analisar a expressão do fator transcricional indutível por hipóxia HIF1A e a de seus genes-alvo relacionados à angiogênese, como o fator de crescimento endotelial vascular (VEGFA) e à captação de glicose, como as proteínas transportadoras facilitadoras GLUT1/SLC2A1 e GLUT4/SLC2A4 no corpo lúteo canino ao longo do diestro (dias 10 a 70 após a ovulação). Para tal, utilizou-se imuno-histoquímica e western blotting para localizar e quantificar as proteínas do HIF1A, GLUT1 e GLUT4 e PCR em tempo real para quantificar a expressão do RNAm de HIF1A, SLC2A1, SLC2A4, VEGFA, FLT1 e KDR. Além disso, células luteínicas nas fases inicial (dia 10), média (dia 30) e final (dia 60) foram submetidas ao tratamento com cloreto de cobalto (CoCl2) a 500 µM para avaliar os efeitos da hipóxia sobre a expressão gênica dos fatores acima citados, bem como sobre a produção de progesterona e 17β-estradiol. Nossos resultados demonstraram que o HIF1A é expresso pelo corpo lúteo canino de maneira tempo-dependente ao longo do diestro, e que a expressão de seu RNAm está diretamente correlacionada a expressão gênica de SLC2A1, SLC2A4, VEGFA, FLT1 e KDR e com as concentrações de progesterona periférica. No cultivo primário de células luteínicas, a hipóxia induzida pelo CoCl2 diminuiu a produção de progesterona e de 17β-estradiol e estimulou significativamente a expressão de HIF1A, SLC2A1, SLC2A4 e VEGFA. Esses resultados sugerem que o HIF1A constitui um dos fatores regulatórios da função do corpo lúteo canino participando da modulação de processos como esteroidogêne, angiogênese e da captação de glicose, atuando como fator luteolítico
This study was designed to investigate if hypoxia is one of the triggers of luteal regression in non-pregnant bitches. For that, we analyzed the hypoxia- inducible factor (HIF1A) expression as well as the expression of its target genes related to angiogenesis (vascular endothelial growth factor VEGFA) and to glucose uptake (glucose transporters GLUT/SLC2A 1 and 4) in canine corpus luteum throughout diestrus (days 10 to 70 after ovulation). We used immunohistochemistry and western blotting to localize and quantify the protein expression of HIF1A, GLUT1 and GLUT4, respectively, and real time PCR to analyze HIF1A, SLC2A1, SLC2A4, VEGFA, FLT1 and KDR gene expression. Moreover, luteal cells from early (day 10), mid (day 30) and late luteal phase (day 60) were submitted to 500 µM cobalt chloride (CoCl2) treatment to verify hypoxia effects on gene expression of the above cited genes and on progesterone and 17β-estradiol production. Our results showed that luteal cells expressed HIF1A in a time-dependent manner over diestrus and that its expression was directly correlated to both SLC2A1, SLC2A4, VEGFA, FLT1 and KDR gene expression and progesterone production. The protein expression of the studied genes also changed over diestrus and was correlated with the respective gene expression. In primary luteal cells culture, cobalt chloride-induced hypoxia downregulated progesterone and 17β-estradiol production, but upregulated HIF1A, SLC2A1, SLC2A4 and VEGFA gene expression. These findings suggest that HIF1A is one of the factors regulating canine luteal function by modulating important process as steroidogenesis, angiogenesis and glucose uptake, acting as a pro-survival factor